Current trends in the use of the renin-angiotensin system blocking drugs in renovascular arterial hypertension

Renovascular hypertension (RH) is one of the most common secondary forms arterial hypertension, in cases caused by atherosclerotic renal artery stenosis (ARAS). The development a course resistant to antihypertensive therapy with an unfavorable prognosis deterioration kidney function and cardiovascular complications characteristic. review discusses pathophysiological mechanisms RH ARAS, draws attention important role renin-angiotensin system (RAS) activation, which determines nature disease, high frequency target organ damage. Modern approaches drug treatment this form validity benefits use drugs that block effects RAS patients genesis, constituting category risk complications, are issues effectiveness these order reduce improve long-term discussed.